Germany · Delayed Price · Currency is EUR Pharmanutra Statistics
Total Valuation
Pharmanutra has a market cap or net worth of EUR 546.42 million. The enterprise value is 545.44 million.
| Market Cap | 546.42M |
| Enterprise Value | 545.44M |
Important Dates
The last earnings date was Wednesday, November 19, 2025.
| Earnings Date | Nov 19, 2025 |
| Ex-Dividend Date | May 5, 2025 |
Share Statistics
| Current Share Class | 9.60M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | +2.76% |
| Owned by Insiders (%) | 10.77% |
| Owned by Institutions (%) | 12.73% |
| Float | 4.25M |
Valuation Ratios
The trailing PE ratio is 31.32 and the forward PE ratio is 26.21.
| PE Ratio | 31.32 |
| Forward PE | 26.21 |
| PS Ratio | 4.30 |
| PB Ratio | 8.27 |
| P/TBV Ratio | 13.11 |
| P/FCF Ratio | 52.42 |
| P/OCF Ratio | 37.82 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.23, with an EV/FCF ratio of 52.33.
| EV / Earnings | 31.26 |
| EV / Sales | 4.29 |
| EV / EBITDA | 17.23 |
| EV / EBIT | 19.36 |
| EV / FCF | 52.33 |
Financial Position
The company has a current ratio of 2.19, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.19 |
| Quick Ratio | 1.60 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | 2.01 |
| Interest Coverage | 37.27 |
Financial Efficiency
Return on equity (ROE) is 27.73% and return on invested capital (ROIC) is 20.67%.
| Return on Equity (ROE) | 27.73% |
| Return on Assets (ROA) | 14.96% |
| Return on Invested Capital (ROIC) | 20.67% |
| Return on Capital Employed (ROCE) | 31.78% |
| Revenue Per Employee | 934,934 |
| Profits Per Employee | 128,294 |
| Employee Count | 118 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 6.81 |
Taxes
In the past 12 months, Pharmanutra has paid 11.07 million in taxes.
| Income Tax | 11.07M |
| Effective Tax Rate | 38.98% |
Stock Price Statistics
The stock price has increased by +2.72% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +2.72% |
| 50-Day Moving Average | 46.88 |
| 200-Day Moving Average | 48.40 |
| Relative Strength Index (RSI) | 71.09 |
| Average Volume (20 Days) | 16 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharmanutra had revenue of EUR 127.15 million and earned 17.45 million in profits. Earnings per share was 1.82.
| Revenue | 127.15M |
| Gross Profit | 65.20M |
| Operating Income | 28.18M |
| Pretax Income | 28.39M |
| Net Income | 17.45M |
| EBITDA | 31.20M |
| EBIT | 28.18M |
| Earnings Per Share (EPS) | 1.82 |
Balance Sheet
The company has 21.97 million in cash and 20.98 million in debt, giving a net cash position of 981,000.
| Cash & Cash Equivalents | 21.97M |
| Total Debt | 20.98M |
| Net Cash | 981,000 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 66.07M |
| Book Value Per Share | 6.85 |
| Working Capital | 36.99M |
Cash Flow
In the last 12 months, operating cash flow was 14.45 million and capital expenditures -4.02 million, giving a free cash flow of 10.42 million.
| Operating Cash Flow | 14.45M |
| Capital Expenditures | -4.02M |
| Free Cash Flow | 10.42M |
| FCF Per Share | n/a |
Margins
Gross margin is 51.28%, with operating and profit margins of 22.16% and 13.72%.
| Gross Margin | 51.28% |
| Operating Margin | 22.16% |
| Pretax Margin | 22.33% |
| Profit Margin | 13.72% |
| EBITDA Margin | 24.54% |
| EBIT Margin | 22.16% |
| FCF Margin | 8.20% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 1.77%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 1.77% |
| Dividend Growth (YoY) | 17.65% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 54.97% |
| Buyback Yield | 0.58% |
| Shareholder Yield | 2.35% |
| Earnings Yield | 3.19% |
| FCF Yield | 1.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Pharmanutra has an Altman Z-Score of 7.83 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.83 |
| Piotroski F-Score | 6 |